Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19
Study sponsor: OPKO Health, Inc. · OPK
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2021-10-08Actual
Enrollment · participants171Actual
Source updated2024-05-28Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.